Literature DB >> 11843917

Pseudomonas aeruginosa: antibiotic susceptibility and genotypic characterization of strains isolated in the intensive care unit.

X Bertrand1, M Thouverez, C Patry, P Balvay, D Talon.   

Abstract

A prospective study was carried out to assess the incidence and the local antibiotic susceptibility of Pseudomonas aeruginosa in intensive care units (ICUs) and to characterize cross-transmission by using pulsed-field gel electrophoresis as an epidemiologic tool. For this purpose, we screened surveillance cultures and routine clinical cultures from patients admitted to two adult ICUs during a 2-year period. Antibiotic susceptibility was determined by a disk diffusion method. The overall incidence of P. aeruginosa was 19.1 cases per 100 patients. Our findings concerning the antibiotic resistance of clinical isolates were concordant with those of other studies. Genotyping revealed that approximately 53.5% of P. aeruginosa colonization was acquired via cross-transmission; the other cases probably originated from endogenous sources. Cross-colonization seems to make a large contribution to the spread of P. aeruginosa in ICUs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11843917

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  3 in total

1.  Prevalence of Pseudomonas aeruginosa in post-operative wound infection in a referral hospital in Haryana, India.

Authors:  K Prabhat Ranjan; Neelima Ranjan; Satish K Bansal; D R Arora
Journal:  J Lab Physicians       Date:  2010-07

2.  Antibiotic sensitivity profile of bacterial pathogens in postoperative wound infections at a tertiary care hospital in Gujarat, India.

Authors:  Nutanbala N Goswami; Hiren R Trivedi; Alpesh Puri P Goswami; Tejas K Patel; C B Tripathi
Journal:  J Pharmacol Pharmacother       Date:  2011-07

3.  The role of water fittings in intensive care rooms as reservoirs for the colonization of patients with Pseudomonas aeruginosa.

Authors:  Pascal Cholley; Michelle Thouverez; Nathalie Floret; Xavier Bertrand; Daniel Talon
Journal:  Intensive Care Med       Date:  2008-04-19       Impact factor: 17.440

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.